Agenus Inc.

0.67 USD
-0.08 (-10.80%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Agenus Inc. stock is up 6.37% since 30 days ago. The next earnings date is Mar 12, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 37.5% of the previous 24 March’s closed higher than February. In the last 2 Unusual Options Trades, there were 2 CALLs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
15 Feb 15:09 17 Jan, 2025 3.00 CALL 3000 11238
15 Feb 15:20 17 Jan, 2025 3.00 CALL 6800 11238

About Agenus Inc.

Agenus Inc. discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It also develops Balstilimab, an anti-PD-1 antagonist that has completed Phase II clinical trial to treat second line cervical cancer.